Inflammatory biomarker profile in children with cystic fibrosis: preliminary study

N H Slobodianik1, M S Feliu, P Perris

  • 1Department of Nutrition and Food Science, School of Pharmacy and Biochemistry, University of Buenos Aires, Bueno Aires, Argentina. nslobo@ffyb.uba.ar

Insights

This study found lower antioxidant capacity and abnormal nutritional markers in children with cystic fibrosis (CF). Elevated inflammation markers suggest a need for early biochemical evaluation in CF patients.

Area of Science:

  • Biochemistry
  • Pediatric Nutrition
  • Immunology

Background:

  • Cystic Fibrosis (CF) is a genetic disorder affecting multiple organs, often leading to nutritional deficiencies and inflammation.
  • Early identification of nutritional status and inflammatory markers is crucial for managing CF patients.

Purpose of the Study:

  • To determine specific proteins related to inflammation, nutritional status, and total antioxidant capacity (TAC) in children with CF.
  • To compare these markers between CF patients and a healthy reference group.
  • To highlight the need for early biochemical evaluation in CF management.

Main Methods:

  • Study included 17 nonhospitalized children with CF (3 months-10 years).
  • Measured transferrin, transthyretin, ceruloplasmin (Cp), haptoglobin, C-reactive protein (CRP), and fibrinogen using single radial immunodiffusion.
  • Assessed Total Antioxidant Capacity (TAC) via decolorization assay and analyzed data using Student's t test.

Main Results:

  • CF patients showed lower transferrin and transthyretin levels, indicating abnormal nutritional status.
  • Elevated levels of ceruloplasmin (Cp) and haptoglobin were observed in CF patients.
  • A significant percentage of CF patients exceeded desirable limits for fibrinogen and CRP, with lower TAC compared to healthy children.

Conclusions:

  • Diminished TAC and increased Cp in CF patients may exacerbate inflammation and impair immune function.
  • These preliminary findings underscore the importance of biochemical and functional parameters for early nutritional assessment in CF.
  • Optimized nutritional and pharmacological therapies, guided by early evaluation, can improve survival and quality of life for CF patients.